Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of Two Novel Truncating Mutations in the Apob Gene Leading to Hypobetalipoproteinemia: A Pilot Study

NCT03963037 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT03963037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of Two Novel Truncating Mutations in the Apob Gene Leading to Hypobetalipoproteinemia: A Pilot Study
Lead sponsor
Medical University Innsbruck
Phase
Observational
Overall status
Unknown status
Start date
January 24, 2019
Completion date
January 31, 2022
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypobetalipoproteinaemia - heterozygous form, low-ldl-syndrome